IPO Boutique

Rhythm Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Rhythm Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Rhythm Pharmaceuticals, Inc.RYTM -
NASDAQ
$14.00-$16.00 $17.00 $23.217.05 million10/5/2017
Morgan Stanley, BofA Merrill Lynch, Cowen & Co.
Co-Manager(s):
Needham & Co.
Health Care
Filing(s):

1st Filed 2014-08-27
Filed 2017-09-05
Terms Added 2017-09-25



Rhythm Pharmaceuticals, Inc. Quote & Chart - Click for current quote - RYTM

About Rhythm Pharmaceuticals, Inc. (adapted from Rhythm Pharmaceuticals, Inc. prospectus):
They are a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.

This description is adapted from Rhythm RYTM prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Rhythm RYTM "RYTM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved